What are the recommended indications, dosing regimens, and safety precautions for N‑acetylcysteine (N‑acetylcysteine) in adolescents?

NAC for Teens

For acetaminophen overdose in adolescents, administer N-acetylcysteine using a weight-based loading dose of 140 mg/kg followed by maintenance doses of 70 mg/kg every 4 hours for 17 additional doses, with treatment decisions guided by the Rumack-Matthew nomogram for acute ingestions with known timing 1, 2.

Primary Indication: Acetaminophen Overdose

NAC is FDA-approved and guideline-recommended specifically for acetaminophen toxicity in adolescents 1, 2. The decision to treat depends on:

• Acute ingestion with known timing (4-24 hours post-ingestion): Plot serum acetaminophen level on the Rumack-Matthew nomogram. Treat if the level falls above the treatment line 1, 2
• Unknown timing, chronic ingestion, or delayed presentation: Treat empirically if there is any concern for hepatotoxicity (elevated AST) or if acetaminophen level is detectable with any transaminase elevation 1

Dosing Regimen for Acetaminophen Overdose

Oral route (preferred if patient can tolerate):

• Loading dose: 140 mg/kg as a 5% solution (dilute 20% solution 1:3 with cola, juice, or water)
• Maintenance: 70 mg/kg every 4 hours for 17 additional doses (total 72 hours of treatment) 2

Intravenous route (if vomiting, altered mental status, or oral intolerance):

• Two-bag regimen is preferred over traditional three-bag in pediatrics due to significantly fewer medication errors (23% vs 39%, p=0.01) and fewer cutaneous reactions (2% vs 10%, p=0.02) 3
• Loading: 150 mg/kg over 1 hour, then 10 mg/kg/hour continuous infusion for 20 hours 4, 3
• Critical safety point: Use 0.45% saline with 5% dextrose (NOT 5% dextrose alone) to prevent symptomatic hyponatremia in children 4

Timing Is Critical

Hepatotoxicity prevention is directly related to how quickly NAC is initiated. Treatment within 8 hours of ingestion provides near-complete protection; efficacy decreases significantly after 10-12 hours but NAC should still be given even in delayed presentations as it provides benefit through multiple mechanisms beyond glutathione repletion 1, 5.

Off-Label Psychiatric Indications

For obsessive-compulsive disorder (OCD) refractory to SSRIs or cognitive behavioral therapy, NAC may be considered as augmentation therapy at 2400-2700 mg/day in divided doses 6.

Evidence quality: Two small randomized controlled trials in adolescents with OCD showed statistically significant improvements, though only one demonstrated clear clinical relevance 6. A trial in trichotillomania showed no benefit over placebo 6.

Practical approach:

• Reserve for patients who have failed first-line treatments (SSRIs and/or CBT)
• Titrate gradually over 10-12 weeks to target dose of 2400-2700 mg/day
• Monitor for mild adverse effects: nausea, blurred vision, fatigue, tremor 6

This indication remains investigational with limited evidence, but the favorable safety profile makes it a reasonable option when standard treatments have failed 6, 7.

Respiratory Indications

For chronic respiratory conditions (cystic fibrosis, chronic bronchitis), oral NAC 200 mg three times daily is generally effective and well-tolerated in children over 9 years 8.

For younger children (2-9 years) with acute respiratory conditions, use weight-based dosing of 20 mg/kg/day due to significant weight variations in this age group 8.

Important caveat: Evidence for respiratory benefits is mixed and most robust in older children. Nebulized NAC can be administered at 3-5 mL of 20% solution 3-4 times daily for mucolytic effects 2, though clinical benefit varies by condition.

Safety Precautions

Anaphylactoid reactions (non-allergic):

• More common with IV administration, particularly during the loading dose
• Manifests as flushing, pruritus, bronchospasm, hypotension
• Management: Slow or stop infusion temporarily; reactions typically resolve without treatment; antihistamines if needed
• The two-bag IV regimen reduces these reactions compared to traditional three-bag 3

Hyponatremia risk:

• Occurs when NAC is diluted in hypotonic solutions (5% dextrose alone)
• Prevention: Always use 0.45% saline with 5% dextrose for IV administration in children 4

Gastrointestinal effects:

• Nausea and vomiting common with oral route
• Dilute in cola or juice to improve palatability and mask sulfur odor
• Consider antiemetics if needed; switch to IV route if persistent vomiting 2

Medication errors:

• Complex three-bag dosing leads to 39% error rate in pediatrics
• Two-bag regimen reduces errors to 23% 3
• Always verify weight-based calculations independently